Medicure Inc. (NGQ1)
XDUS
1.81
+0.02 (+1.12%)
Closed
Oct 8, 2026
Day's Range
1.811.81
52 wk Range
0.50001.81
Financial Statements - NGQ1 - Medicure Inc.
Revenue
28.85M▲ 31.7%
Net Income
-7.09M▼ 583.1%Net Margin -24.6%
EBITDA
-4.04M▼ 350.7%
Free Cash Flow
-560.00K▼ 187.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 28.85M | 21.90M |
| Cost of Goods | 17.10M | 8.81M |
| Gross Profit | 11.74M | 13.08M |
 Operating Expense | - | - |
| Operating Income | -6.88M | -2.73M |
| Non-Operating Interest | - | - |
| Other Income Expense | -150K | 1.78M |
| Pre Tax Income | -6.88M | -783K |
| Income Tax | 208K | 256K |
| Net Income | -7.09M | -1.03M |
| EPS Basic | -0.68 | -0.1 |
| EPS Diluted | -0.68 | -0.1 |
| Basic Shares Outstanding | 10.43M | 10.43M |
| Diluted Shares Outstanding | 10.43M | 10.43M |
| Ebit | -6.83M | -773K |
| Ebitda | -4.04M | 1.61M |
| Net Income Continuous Operations | -7.09M | -1.03M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
